Category English

WHO Chief: No Government Should Be Intimidated For Doing “Right Thing” In Public Health

Discussions on access to essential medicines yesterday at the World Health Organization were in some ways overshadowed by the recent leak of a global pharmaceutical campaign aimed at derailing efforts by the South African government to revise its intellectual property policy. WHO Director General Margaret Chan strongly supported South Africa, as did several developing countries, while developed countries remained silent on the subject.

WHO Board Tackles Reform, Engagement With Non-State Actors

The World Health Organization Executive Board spent long hours this week discussing the progress of the reform of the organisation. Among items covered were the reform implementation plan, the engagement of WHO with non-state actors, and ways to improve decision-making by the organisation’s governing bodies.

Year Ahead: Copyright Issues Top EU IP Policy In 2014

Copyright tops the European Union intellectual property agenda this year, with completion of a collective rights management directive, and European Commission statements on IP rights enforcement and possible revisions to EU copyright rules, due this spring. “Steady progress” on rollout of a unified EU patent and patent court system is expected, and trademark and other issues also figure prominently. But with European Parliament elections in May, and a new Commission in November, the timetables for these and other IP-related issues could shift, the EC and others said.

Global Health 2035 Report: Flawed Projections

Daniele Dionisio writes: Hopes that a comprehensive global health goal could be reached by 2035 are hardly credible with the load of unresolved issues still on the table. This article turns the spotlight on much-debated relevant questions that were left out or under-scrutinised in a recently published Lancet report.

Vaccines In Middle-Income Countries, Non-Communicable Diseases Discussed At WHO

Availability and accessibility of vaccines in middle-income countries was raised today at the World Health Organization as member states are ploughing through a heavy agenda. Noncommunicable diseases were also discussed and delegates sitting on the Executive Board agreed on a formal meeting before the next World Health Assembly to complete terms of reference for a global coordination mechanism to prevent and control the growing epidemic.

WHO Executive Board Opens With Overcrowded Agenda; Chan Calls For Focus

The World Health Organization Executive Board opened this morning with a packed agenda, which prompted the chair to warn participants to restrict their statements. Director General Margaret Chan described as problematic the temptation to address all public health issues, and encouraged member states to focus on strategic and selective goals. Member countries also expressed concerns about the length of the agenda.

WHO Board To Discuss Relationship With Industry, Organisations

The World Health Organization has been soul-searching for several years since running into deep debt and seeing private organisations gather influence in global public health policy. Next week, the WHO Board will consider a proposal on how to allow the intergovernmental body work with such organisations and industry without giving up its own independence and oversight role.

India: The Full Spectrum On FDI In Brownfield Companies

DG Shah writes: Acquisition of brownfield, or existing, pharmaceutical companies may be seen in different perspectives as greenfield, or new, projects are permitted 100% equity via the automatic route. India has sought FDI mainly to bridge the shortfall in investment or to facilitate the flow of know-how and technology. We must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.